Plasma Serum Based Biomarkers in Sublingual Oral Immunotherapy for Milk Allergy
基于血浆血清的生物标志物用于舌下口服免疫疗法治疗牛奶过敏
基本信息
- 批准号:8241529
- 负责人:
- 金额:$ 24.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-15 至 2014-01-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcidsAddressAdolescenceAdultAdverse reactionsAffectAftercareAllergen ImmunotherapyAllergensAllergicAntibodiesAreaBasophilsBiological AssayBiological MarkersBloodCD34 geneCattleChildClinicalComplexDataDendritic CellsDevelopmentDietDiseaseEffectivenessElementsFoodFood ContaminationFood HypersensitivityFood ProcessingFutureGoalsHandHistamineHistamine ReleaseHypersensitivityIgEIgG4Immune responseImmunoglobulin GImmunoglobulinsImmunotherapyIn VitroIndividualInstitutionInterferonsInterleukin-4LinkLiquid substanceMediatingMilkMilk HypersensitivityMilk ProteinsMonitorOralPatient CarePatientsPilot ProjectsPlasmaPlayPre-Post TestsProcessProductionReactionRecording of previous eventsRelative (related person)ReportingResearch Project GrantsRestaurantsRiskRoleSafetySamplingSerumSpecimenTestingTimeWorkadult stem cellairborne allergenassay developmentbaseclinical efficacyclinically relevantcrosslinkcytokinedesensitizationeffective therapyfollow-upfood allergenhuman SYK proteinin vitro testingnovel strategiesomalizumaboral immunotherapypassive sensitizationreceptorresearch studyresponse
项目摘要
DESCRIPTION (provided by applicant): Cow's milk allergy (CMA) is the most common food allergy in young children and is now likely to persist into adolescence and adulthood. Strict milk avoidance remains the only treatment for this allergy but accidental reactions, which are often severe, are extremely common, frequently due to the hidden presence of food allergens in processed foods and cross-contamination of foods. Recent studies from our institution and elsewhere have identified oral and sublingual allergen immunotherapy (OIT and SLIT) as promising approaches for treatment of CMA. Studies demonstrate that most children with IgE-mediated CMA can be desensitized to cow's milk protein, both safely and efficaciously. However, the specific mechanisms by which this treatment appears to work remain unknown, and questions remain to whether this increased tolerance to milk after treatment is permanent, or rather represents a transient desensitization which could place patients at significant risk of future reactions if milk was ever discontinued from their diet. Our long-range goal is to develop in vitro tests that help predict risks to adverse reactions to food as well as the safety/clinical efficacy of OIT/SLIT. The best chance of developing a routine test to make such predictions is best achieved with the versatility that serum/plasma provides. Our novel approach of using culture-derived basophils (CDBA) grown from adult stem cells should facilitate identification of plasma markers. Therefore, the proposal consists of 2 aims: Aim 1 involves analyzing plasma from CMA children undergoing SLIT and OIT for "blocking activity" by comparing pre and post specimens in passively sensitizing CDBA for subsequent challenge with milk allergen. The advantage of using CDBA is that they have never been exposed to immunoglobulins (IgE/IgG), which may otherwise confound the ability to detect blocking IgG4 antibody. Similar experiments will test pre- and post- OIT/SLIT plasma specimens for effects on plasmacytoid dendritic cells (pDCs), predicting that post-OIT/SLIT plasma (with greater IgG4 levels) will augment innate immune responses (TLR9) that are seemingly impaired in allergic individuals. Aim 2 explores the existing hypothesis that circulating allergen-IgE complexes are in plasma of CMA subjects and that these can be detected by inducing phenotypic/functional responses in CDBA and/or normal basophil. Plasma specimens from CMA subjects will be tested in flow-based assays for their ability to induce basophil spontaneous histamine release (SHR), the expression of markers (CD63/CD203c) linked to IgE-dependent activation as well as those (syk kinase) that are down regulated with prolonged Fc5RI cross-linking. These assays could result in new plasma-based tests useful in predicting whether one is at risk for adverse reactions and for predicting the clinical efficacy during successful OIT/SLIT. With food specific immunotherapy being potentially the most exciting area in the history of food allergy research, this project, with clinical and mechanistic endpoints should have immediate impact on the care of patients with food allergy.
PUBLIC HEALTH RELEVANCE: Allergy to cow's milk is the most common food allergy in young children, and this allergy is likely to persist into adolescence and adulthood. Better tests are needed in helping to predict adverse reactions and/or monitor the safety and effectiveness of new treatments. We believe we can develop such tests by investigating unique elements within the plasma (liquid part of blood) from milk allergic children undergoing a new kind of therapy.
描述(由申请人提供):牛奶过敏(CMA)是幼儿中最常见的食物过敏,现在可能会持续到青春期和成年期。严格避免牛奶仍然是这种过敏的唯一治疗方法,但意外反应非常常见,通常很严重,通常是由于加工食品中隐藏的食物过敏原和食品交叉污染造成的。我们机构和其他地方的最新研究已确定口腔和舌下过敏原免疫疗法(OIT 和 SLIT)是治疗 CMA 的有前途的方法。研究表明,大多数患有 IgE 介导的 CMA 的儿童可以安全有效地对牛奶蛋白进行脱敏。然而,这种治疗起作用的具体机制仍然未知,而且治疗后这种对牛奶的耐受性增加是否是永久性的,或者更确切地说代表一种短暂的脱敏,如果停止牛奶,可能会使患者面临未来反应的重大风险,这一问题仍然存在。我们的长期目标是开发体外测试,帮助预测食品不良反应的风险以及 OIT/SLIT 的安全性/临床疗效。开发常规测试来进行此类预测的最佳机会是通过血清/血浆提供的多功能性来实现。我们使用从成体干细胞生长的培养物衍生的嗜碱性粒细胞(CDBA)的新方法应该有助于血浆标记物的鉴定。因此,该提案包含 2 个目标: 目标 1 涉及通过比较被动致敏 CDBA 之前和之后的样本来分析接受 SLIT 和 OIT 的 CMA 儿童血浆的“阻断活性”,以用于随后的牛奶过敏原挑战。使用 CDBA 的优点是它们从未接触过免疫球蛋白 (IgE/IgG),否则可能会混淆检测阻断 IgG4 抗体的能力。类似的实验将测试 OIT/SLIT 前后血浆样本对浆细胞样树突状细胞 (pDC) 的影响,预测 OIT/SLIT 后血浆(具有更高的 IgG4 水平)将增强先天免疫反应(TLR9),而先天免疫反应似乎在过敏个体中受损。目标 2 探讨了现有的假设,即循环过敏原-IgE 复合物存在于 CMA 受试者的血浆中,并且可以通过诱导 CDBA 和/或正常嗜碱性粒细胞的表型/功能反应来检测这些复合物。来自 CMA 受试者的血浆样本将通过基于流式的检测来测试其诱导嗜碱性粒细胞自发组胺释放 (SHR) 的能力、与 IgE 依赖性激活相关的标记物 (CD63/CD203c) 的表达以及那些随着 Fc5RI 长时间交联而下调的标记物 (syk 激酶) 的表达。这些测定可能会产生新的基于血浆的测试,可用于预测一个人是否面临不良反应的风险,并预测成功的 OIT/SLIT 期间的临床疗效。由于食物特异性免疫疗法可能是食物过敏研究史上最令人兴奋的领域,因此该项目及其临床和机制终点应该会对食物过敏患者的护理产生直接影响。
公共卫生相关性:对牛奶过敏是幼儿中最常见的食物过敏,这种过敏可能会持续到青春期和成年期。需要更好的测试来帮助预测不良反应和/或监测新疗法的安全性和有效性。我们相信,我们可以通过研究接受新疗法的牛奶过敏儿童的血浆(血液的液体部分)中的独特元素来开发此类测试。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN T. SCHROEDER其他文献
JOHN T. SCHROEDER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN T. SCHROEDER', 18)}}的其他基金
Galectins in Modulating Immune Responsiveness of IgE-bearing Cells
半乳糖凝集素调节 IgE 细胞的免疫反应
- 批准号:
10651597 - 财政年份:2019
- 资助金额:
$ 24.3万 - 项目类别:
Epithelial Cell-dependent Activation of Human Basophils
人类嗜碱性粒细胞的上皮细胞依赖性激活
- 批准号:
9179854 - 财政年份:2016
- 资助金额:
$ 24.3万 - 项目类别:
Plasma Serum Based Biomarkers in Sublingual Oral Immunotherapy for Milk Allergy
基于血浆血清的生物标志物用于舌下口服免疫疗法治疗牛奶过敏
- 批准号:
8424318 - 财政年份:2012
- 资助金额:
$ 24.3万 - 项目类别:
Basophils in Modulating Th2 Responses in Human Allergic Disease
嗜碱性粒细胞调节人类过敏性疾病中的 Th2 反应
- 批准号:
8308732 - 财政年份:2011
- 资助金额:
$ 24.3万 - 项目类别:
Innate Immune Function of FcERI-Bearing Cells
携带 FcERI 的细胞的先天免疫功能
- 批准号:
7150228 - 财政年份:2006
- 资助金额:
$ 24.3万 - 项目类别:
Differential Cytokine Secretion by Human Basophils
人类嗜碱性粒细胞的差异细胞因子分泌
- 批准号:
6856521 - 财政年份:1998
- 资助金额:
$ 24.3万 - 项目类别:
Differential Cytokine Secretion by Human Basophils
人类嗜碱性粒细胞的差异细胞因子分泌
- 批准号:
7191604 - 财政年份:1998
- 资助金额:
$ 24.3万 - 项目类别:
相似国自然基金
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
- 批准号:22007039
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
- 批准号:
- 批准年份:2019
- 资助金额:10.0 万元
- 项目类别:省市级项目
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
- 批准号:21372217
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
- 批准号:21172061
- 批准年份:2011
- 资助金额:30.0 万元
- 项目类别:面上项目
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
- 批准号:21176225
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
- 批准号:81072511
- 批准年份:2010
- 资助金额:31.0 万元
- 项目类别:面上项目
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
- 批准号:30660215
- 批准年份:2006
- 资助金额:21.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Lipid nanoparticle-mediated Inhalation delivery of anti-viral nucleic acids
脂质纳米颗粒介导的抗病毒核酸的吸入递送
- 批准号:
502577 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
CAREER: Highly Rapid and Sensitive Nanomechanoelectrical Detection of Nucleic Acids
职业:高度快速、灵敏的核酸纳米机电检测
- 批准号:
2338857 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
Continuing Grant
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Synthetic analogues based on metabolites of omega-3 fatty acids protect mitochondria in aging hearts
基于 omega-3 脂肪酸代谢物的合成类似物可保护衰老心脏中的线粒体
- 批准号:
477891 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Operating Grants
Metabolomic profiles of responders and non-responders to an omega-3 fatty acids supplementation.
对 omega-3 脂肪酸补充剂有反应和无反应者的代谢组学特征。
- 批准号:
495594 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrated understanding and manipulation of hypoxic cellular functions by artificial nucleic acids with hypoxia-accumulating properties
具有缺氧累积特性的人工核酸对缺氧细胞功能的综合理解和操纵
- 批准号:
23H02086 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)